Atreca, Inc.

📍 South San Francisco, United States🗓 Founded 2011👥 99 employees💰 Last funded 2012
Biotechnology Research🌐 atreca.com
Website LinkedIn
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. Atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. Atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. If you are interested in becoming part of the Atreca team, our open positions can be found at: http://www.atreca.com/careers/
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Atreca, Inc.?
Atreca, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Atreca, Inc. last raise funding?
The most recent investment in Atreca, Inc. recorded on gritt.io was in 2012.
When was Atreca, Inc. founded?
Atreca, Inc. was founded in 2011.
What industry is Atreca, Inc. in?
Atreca, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Atreca, Inc. based?
Atreca, Inc. is headquartered in South San Francisco, United States.